William Lay
Chief Executive Officer at MELODIOL GLOBAL HEALTH LIMITED
Net worth: 2 038 $ as of 31/03/2024
Profile
Mr. William Lay is a Chief Executive Officer, Director & MD at Melodiol Global Health Ltd.
and a Group Chief Executive Officer at Creso Pharma US, Inc. He is on the Board of Directors at Melodiol Global Health Ltd.
Mr. Lay was previously employed as an Associate Director by Canopy Growth Corp.
and a Chief Strategy Officer & Executive Vice President by Red Light Holland Corp.
He received his undergraduate degree from Queen's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/01/2023 | 625,000 ( 0.15% ) | 2 038 $ | 31/03/2024 |
William Lay active positions
| Companies | Position | Start |
|---|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 17/01/2022 |
Creso Pharma US, Inc.
 Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Chief Executive Officer | 01/01/2022 |
Former positions of William Lay
| Companies | Position | End |
|---|---|---|
| CANOPY GROWTH CORPORATION | Corporate Officer/Principal | 01/09/2020 |
| RED LIGHT HOLLAND CORP | Corporate Officer/Principal | - |
Training of William Lay
| Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CANOPY GROWTH CORPORATION | Process Industries |
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| RED LIGHT HOLLAND CORP | Process Industries |
| Private companies | 1 |
|---|---|
Creso Pharma US, Inc.
Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- William Lay
